OptimizeRx Corp — Director's Dealing 2017

Apr 4, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2017-03-31

Reporting Person: Hamilton Terrence (SVP OF SALES)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-03-31	Stock Option	$0.82	A	200000	Acquired	2022-03-31	Common Stock (200000)	Direct

Footnotes

F1: The Stock Options were issued based on performance criteria and only vest upon target revenue achieved in 2017.